The pandemic is making it harder for drug companies to develop treatments for other life-threatening diseases
1 min readThe pandemic is making it harder for drug companies to develop treatments for other life-threatening diseases
- The coronavirus pandemic delayed other potentially life-saving medicines from beginning clinical trials, and it may delay them from hitting the market, too.
- This is because several companies, including Eli Lilly and Bristol Myers Squibb, de…